
materresearch.org.au
Jul 26, 2025, 18:15
Medicinal Cannabis for Symptom Control in Advanced Cancer – MASCC
The Multinational Association of Supportive Care in Cancer (MASCC) shared a post on LinkedIn:
“New open access article in Supportive Care in Cancer: Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol.”
Title: Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol
Authors: Janet R. Hardy, Ristan M. Greer, Anita M. Pelecanos, Georgie E. Huggett, Alison M. Kearney, Taylan H. Gurgenci, Phillip D. Good
Read the Full Article.
More posts featuring MASCC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 26, 2025, 21:46
Jul 26, 2025, 21:30
Jul 26, 2025, 21:09
Jul 26, 2025, 20:53
Jul 26, 2025, 20:13
Jul 26, 2025, 18:15